These data imply that combined modalities of chemotherapy to sensitize the tumor cell to Fas-mediated apoptosis and CTL immunotherapy is an effective approach for the suppression of colon cancer metastasis [156]. The gene discussed is FAS; the disease is colonic neoplasm.